Author

Agata Turowski

Institution: University of Chicago Medical Center

Observed institutions: University of Chicago, University of Chicago Medical Center

OpenAlex ID: A5018458035

Phase 1 study of selinexor plus carfilzomib and dexamethasone for the treatment of relapsed/refractory multiple myeloma

2019 · Andrzej J. Jakubowiak, Jagoda K. Jasielec, et al. · British Journal of Haematology · 69

High Rate of Sustained Minimal Residual Disease Negativity Predicts Prolonged Survival for the Overall Patient Population in the Phase 2 KRd Plus Autologous Stem Cell Transplantation MMRC Trial

2017 · Andrzej Jakubowiak, Noopur Raje, et al. · Blood · 10

Works count: 2

Citation count: 79

H-index: 2

I10-index: 2